Experienced and results-driven Senior Manager in Medical Affairs with a proven track record in the pharmaceutical and healthcare industry. Adept at leading cross-functional teams, developing and implementing medical strategies, and ensuring compliance with regulatory requirements. Strong background in driving scientific and medical initiatives, fostering key opinion leader relationships, and contributing to successful product launches. Skilled in providing medical support, conducting educational programs, and delivering impactful medical insights to shape business decisions. Committed to advancing patient care through evidence-based practices and strategic medical leadership.
PROFFESIONAL AFFILITAION :
Maharashtra Medical Council: Reg Nos: 2008/10/3595
RESEARCH / PUBLICATION WORK :
● “Comparative Study of Glycyrrhiza glabra, Zingiber officinale and Proton Pump Inhibitor on Antiulcer Activities in Albino Rats”
o Status: Dissertation for M.D
● “Prescribing Trends in Antenatal Care at a Tertiary Level Teaching Hospital of Vidarbha Region”
o Status: 1st Author Article Published in Index Journal Res J Pharm Biol Chem Sci Volume 3, Issue 3, 2012 July September page no 865.
● “Audit in Dermatology for Rational Prescribing”
o Status: 2nd Author Article Published in Index Journal Res J Pharm Biol Chem Sci Vol 3; 518, July – September 2012.
● “Prescribing Trend of Analgesics in a Tertiary Health Care Setup of Rural Vidarbha: A Critical Appraisal”
o Status: 3rd Author Article Published in Index Journal Res J Pharm Biol Chem Sci Vol 3; 566, July - September 2012.
● “Drugs Utilization Pattern in Patients of Antenatal Care at Tertiary Care Teaching Hospital in Central India”
o Status: Paper Presented in South Asian Chapter of American College of Clinical Pharmacology, Mumbai on 27th& 29th August 2011.
● “Factor Influencing Prescribing Behavior of General Practitioner in Rural Health Care Centre of Eastern Maharashtra: A Questionnaire Based Survey”
o Status: Poster Presented in 57th A.C.P.P, New Delhi on December 2011
● “Prescribing Behavior of General Practitioners in Primary Health Care of Eastern Maharashtra”
o Status: Poster Presented in IPSCON 2011, Udipi on December 2011.
● “Drugs Utilization in Antenatal Care at a Tertiary Health Care Teaching Hospital”
o Status: Poster Presented in SOPICON 2012, Jaipur on November 2012.
● “A prescription event monitoring to assess the clinical utility and safety profile of cefuroxime axetil in the community clinical setting of India”
o Status: Poster Presentation in NAPCON – 2016, Mumbai on November 2016.
● “Efficacy and safety of teneligliptin in type 2 diabetes mellitus (T2DM) patients uncontrolled with oral anti-diabetic drugs“
o Status: Poster presented in RSSDI 2017
● “Evaluation of Efficacy and safety of Teneligliptin in T2DM patients with CKD”
o Status: Poster presented in RSSDI 2017
● “Efficacy and safety of switching from other gliptins to teneligliptin in type 2 diabetes patients”
o Status: Poster presented in RSSDI 2017
● “Safety and efficacy of teneligliptin on QT/QTc Interval in indian type 2 diabetic patients”
o Status: Poster Presented in ESICON 2018
● “Effectiveness and safety of Teneligliptin in Indian patients with diabetic kidney disease.”
o Status: Poster Presented in IDF - 2018, Hyderabad
● “Evaluation of Safety of teneligliptin on qt/qtc Interval in Indian type 2 diabetic patients.”
o Status: Poster Presented in RSSDI – 2018
● “Effectiveness of Teneligliptin in T2DM patients uncontrolled on Metformin and Sulfonylurea.”
o Status: Poster Presented in ESICON- 2018
● “Effectiveness of Teneligliptin in type 2 Diabetes Mellitus patients uncontrolled on Insulin therapy.”
o Status: Poster Presented in RSSDI – 2018
● “Evaluation Of Safety And Effectiveness Of Teneligliptin When Shifted From Other Gliptins Uncontrolled With Other OHA’s”
o Status: Poster Presented in ESICON- 2018
● “Evaluation of Safety of teneligliptin on qt/qtc Interval in Indian type 2 diabetic patients.”
o Status: 2nd Author, Published in International Journal of Scientific study. January 2019; 6 (10): 84-87.
● “Effectiveness and safety of Teneligliptin in Indian patients with diabetic kidney disease”
o Status: 2nd Author, Published in International Journal of Scientific study. January 2019; 6 (10): 88-91.
● “Effectiveness and safety of Teneligliptin in Indian patients with diabetic kidney disease.”
o Status: Poster presented in ACPCON - 2019
● An open-label prospective study of the safety and efficacy of Teneligliptin in Indian Type 2 diabetes patients: The “thorough QT/QTc study”
o Status: Initiated, Analyzed and Published in Diabetes, Metabolic syndrome and obesity 2018
● “Retrospective Real-life efficacy assessment of teneligliptin in Indian T2DM patients.”
o Status: Analyzed and Published the article in International Journal of Research in Medical Sciences.
Fellowship in Advance Course in Diabetes
Fellowship in Advance Course in Diabetes